Basket

Record was added to the basket

1.Cost-utility analysis of telaprevir in combination with peginterferon alpha and ribavirin in previously treated patients with chronic hepatitis C

Cost-utility analysis of telaprevir in combination with peginterferon alpha and ribavirin in previously treated patients with chronic hepatitis C / Lukac M. [et al.] . Farmakoekonomika a lieková politika : oficiálny časopis Slovenskej spoločnosti pre farmakoekonomiku. - ISSN 1336-7021 . - Roč. 9, č. 1 (2013), s. [9] : ilustr. (fareb.), schéma, tab.

C 3079
Request a copy DDS
DSD service
From the basket
Citation
Bookmark

Selected documents
Citation

citace PRO
article

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.